		II
		111th CONGRESS
		1st Session
		S. 1630
		IN THE SENATE OF THE UNITED STATES

			August 6, 2009
			Mr. Rockefeller (for
			 himself and Mr. Franken) introduced the
			 following bill; which was read twice and referred to the
			 Committee on
			 Finance

		A BILL
		To amend title XVIII of the Social Security Act to
		  improve prescription drug coverage under Medicare part D and to amend the
		  Public Health Service Act, the Employee Retirement Income Security Act of 1974,
		  and the Internal Revenue Code of 1986, to improve prescription drug coverage
		  under private health insurance, and for other purposes.

		1.Short
			 titleThis Act may be cited as
			 the Affordable Access to Prescription
			 Medications Act of 2009.
		2.Medicare part D
			 prescription drug plans
			(a)In
			 generalSection 1860D–2(b)(4) of the Social Security Act (42
			 U.S.C. 1395w–102(b)(4)) is amended by adding at the end the following new
			 subparagraph:

					(E)Additional
				protections
						(i)In
				generalNotwithstanding any other provision of this part,
				effective for plan years beginning on or after January 1, 2011, a PDP sponsor
				of a prescription drug plan and an MA organization offering an MA–PD plan
				shall, with respect to any co-payment or coinsurance requirements applicable to
				covered part D drugs under the plan, ensure that—
							(I)such required
				co-payment or coinsurance does not exceed the base cost of the covered part D
				drug (as determined by the Secretary);
							(II)such required
				co-payment or coinsurance does not exceed $200 per month for any single covered
				part D drug (30-day supply); and
							(III)such required
				co-payment or coinsurance does not exceed, in the aggregate for all covered
				part D drugs, $500 per month.
							(ii)AdjustmentsThe
				amounts described in clauses (II) and (III) of clause (i) shall be annually
				adjusted to reflect the average of the percentage increase or decrease in the
				Consumer Price Index for all urban consumers (U.S. city average) and the
				percentage increase or decrease in the medical care component of such Consumer
				Price Index during the calendar year preceding the year for which the
				adjustment is being
				made.
						.
			(b)Expansion of
			 exceptions processEffective for plan years beginning on or after
			 January 1, 2011, the Secretary shall expand the formulary tier exception
			 request process under sections 423.560 through 423.636 of title 42, Code of
			 Federal Regulations (as in effect on the date of enactment of this Act), to
			 allow individuals enrolled in a prescription drug plan under part D of title
			 XVIII of the Social Security Act or an MA–PD plan under part C of such title to
			 request an exception for a specialty prescription drug to a plan’s designation
			 of a covered part D drug (as defined in section 1860D–2(e) of such Act (42
			 U.S.C. 1395w–102(e)) as a non-preferred prescription drug.
			(c)MedPAC studies
			 and reports
				(1)Study and
			 report on the medicare part D anti-discrimination clause
					(A)StudyThe
			 Medicare Payment Advisory Commission shall conduct a study on various aspects
			 of the prescription drug program under part D of title XVIII of the Social
			 Security Act and, to the greatest extent practicable, the interaction of such
			 program with Medicare beneficiary access to covered drugs under part B of such
			 title. Such study shall include the following:
						(i)An
			 analysis of—
							(I)the use of
			 specialty tiers for covered part D drugs under prescription drug plans and
			 MA–PD plans; and
							(II)the effect of
			 such specialty tiers on access to care for Medicare beneficiaries.
							(ii)Consideration of
			 the mechanisms described in subparagraph (B) in the context of the provisions
			 of section 1860D–11(e)(2)(D) of the Social Security Act (42 U.S.C.
			 1395w–111(e)(2)(D)) (in this paragraph referred to as the Medicare part
			 D anti-discrimination clause).
						(B)Mechanisms
			 describedThe following mechanisms are described in this
			 subparagraph:
						(i)The
			 use of specialty tiers for covered part D drugs under prescription drug plans
			 and MA–PD plans.
						(ii)The application
			 of segmented coinsurance or copayment structures to covered part D drugs based
			 on certain categories of such drugs or diagnoses.
						(iii)The utilization
			 of other differential benefit structures based on certain conditions and
			 Medicare beneficiaries under prescription drug plans and MA–PD plans, including
			 an analysis of the interaction between such utilization and the effects of such
			 utilization with the Medicare part D anti-discrimination clause.
						(C)ReportNot
			 later than 1 year after the date of enactment of this Act, the Medicare Payment
			 Advisory Commission shall submit to Congress a report containing the results of
			 the study conducted under subparagraph (A), together with recommendations for
			 such legislation and administrative action as the Commission determines
			 appropriate.
					(D)Revised
			 guidanceBased on the results of the study conducted under
			 subparagraph (A), the Secretary shall issue revised guidance regarding the use
			 of mechanisms described in subparagraph (B) to all PDP sponsors offering
			 prescription drug plans under part D of title XVIII of the Social Security Act
			 and Medicare Advantage organizations offering MA–PD plans under part C of such
			 title.
					(2)Study and
			 report on cost-sharing for prescription drugs under parts B and D
					(A)StudyThe
			 Medicare Payment Advisory Commission shall conduct a study on cost-sharing for
			 prescription drugs under parts B and D of title XVIII of the Social Security
			 Act. Such study shall include an analysis of the impact of eliminating
			 cost-sharing for covered part D drugs for Medicare beneficiaries who—
						(i)incur annual
			 out-of-pocket cost-sharing after the initial coverage limit under section
			 1860D–2(b)(3) of such Act (42 U.S.C. 1395w–102) that exceeds 5 percent of the
			 income of the beneficiary (as determined under section 1860D–14(a)(3)(C) of
			 such Act (42 U.S.C. 1395w–114(a)(3)(C)); and
						(ii)do
			 not otherwise qualify for an income-related subsidy under section 1860D–14(a)
			 of such Act (42 U.S.C. 1395w–114(a)) or other extra help or cost-sharing
			 relief.
						(B)ReportNot
			 later than 6 months after the date of enactment of this Act, the Medicare
			 Payment Advisory Commission shall submit to Congress a report containing the
			 results of the study conducted under subparagraph (A), together with
			 recommendations for such legislation and administrative action as the
			 Commission determines appropriate.
					(3)DefinitionsIn
			 this section:
					(A)Covered part D
			 drugThe term covered part D drug has the meaning
			 given such term in section 1860D–2(e) of the Social Security Act (42 U.S.C.
			 1395w–102(e)).
					(B)MA–PD
			 planThe term MA–PD plan has the meaning given such
			 term in paragraph (9) of section 1860D–41(a) of such Act (42 U.S.C.
			 1395w–151(a)).
					(C)Medicare
			 Advantage organizationThe term Medicare Advantage
			 organization has the meaning given such term in section 1859(a)(1) of
			 such Act (42 U.S.C. 1395w–28(a)(1)).
					(D)PDP
			 sponsorThe term PDP sponsor has the meaning given
			 such term in paragraph (13) of such section 1860D–41(a).
					(E)Prescription
			 drug planThe term prescription drug plan has the
			 meaning given such term in paragraph (14) of such section.
					3.Private health
			 insurance
			(a)Group health
			 plans
				(1)Public Health Service Act amendments
					(A)In
			 generalSubpart 2 of part A of title XXVII of the
			 Public Health Service Act is amended
			 by adding at the end the following new section:

							2708.Provisions
				relating to prescription drugs
								(a)In
				generalA group health plan, and a health insurance issuer
				offering group health insurance coverage, that provides coverage for
				prescription drugs shall, with respect to any co-payment or coinsurance
				requirements applicable to such drug coverage, ensure that—
									(1)such required
				co-payment or coinsurance does not exceed the base cost of the prescription
				drug (as determined by the Secretary);
									(2)such required
				co-payment or coinsurance does not exceed $200 per month for any single
				prescription drug (30-day supply); and
									(3)such required
				co-payment or coinsurance does not exceed, in the aggregate for all
				prescription drugs, $500 per month.
									(b)AdjustmentsThe
				amounts described in paragraphs (2) and (3) of subsection (a) shall be annually
				adjusted to reflect the average of the percentage increase or decrease in the
				Consumer Price Index for all urban consumers (U.S. city average) and the
				percentage increase or decrease in the medical care component of such Consumer
				Price Index during the calendar year preceding the year for which the
				adjustment is being made.
								(c)NoticeA group health plan under this part shall
				comply with the notice requirement under section 714(b) of the
				Employee Retirement Income Security Act of
				1974 with respect to the requirements of this section as if such
				section applied to such
				plan.
								.
					(B)Conforming
			 amendmentSection 2723(c) of such Act (42 U.S.C. 300gg–23(c)) is
			 amended by striking section 2704 and inserting sections
			 2704 and 2708.
					(2)ERISA
			 amendments
					(A)In
			 generalSubpart B of part 7 of subtitle B of title I of the
			 Employee Retirement Income Security Act of
			 1974 is amended by adding at the end the following new
			 section:

							715.Provisions
				relating to prescription drugs
								(a)In
				generalA group health plan, and a health insurance issuer
				offering group health insurance coverage, that provides coverage for
				prescription drugs shall, with respect to any co-payment or coinsurance
				requirements applicable to such drug coverage, ensure that—
									(1)such required
				co-payment or coinsurance does not exceed the base cost of the prescription
				drug (as determined by the Secretary of Health and Human Services);
									(2)such required
				co-payment or coinsurance does not exceed $200 per month for any single
				prescription drug (30-day supply); and
									(3)such required
				co-payment or coinsurance does not exceed, in the aggregate for all
				prescription drugs, $500 per month.
									(b)AdjustmentsThe
				amounts described in paragraphs (2) and (3) of subsection (a) shall be annually
				adjusted to reflect the average of the percentage increase or decrease in the
				Consumer Price Index for all urban consumers (U.S. city average) and the
				percentage increase or decrease in the medical care component of such Consumer
				Price Index during the calendar year preceding the year for which the
				adjustment is being made.
								(c)NoticeA group health plan under this part shall
				comply with the notice requirement under section 714(b) with respect to the
				requirements of this section as if such section applied to such
				plan.
								.
					(B)Table of
			 contentsThe table of contents in section 1 of such Act is
			 amended by inserting after the item relating to section 714 the following new
			 item:

								Sec. 715. Provisions relating to
				prescription
				drugs.

							.
					(3)Internal Revenue
			 Code amendments
					(A)In
			 generalSubchapter B of
			 chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the
			 end the following new section:

							9813.Provisions
				relating to prescription drugs
								(a)In
				generalA group health plan, and a health insurance issuer
				offering group health insurance coverage, that provides coverage for
				prescription drugs shall, with respect to any co-payment or coinsurance
				requirements applicable to such drug coverage, ensure that—
									(1)such required
				co-payment or coinsurance does not exceed the base cost of the prescription
				drug (as determined by the Secretary of Health and Human Services);
									(2)such required
				co-payment or coinsurance does not exceed $200 per month for any single
				prescription drug (30-day supply); and
									(3)such required
				co-payment or coinsurance does not exceed, in the aggregate for all
				prescription drugs, $500 per month.
									(b)AdjustmentsThe
				amounts described in paragraphs (2) and (3) of subsection (a) shall be annually
				adjusted to reflect the average of the percentage increase or decrease in the
				Consumer Price Index for all urban consumers (U.S. city average) and the
				percentage increase or decrease in the medical care component of such Consumer
				Price Index during the calendar year preceding the year for which the
				adjustment is being made.
								(c)NoticeA group health plan under this part shall
				comply with the notice requirement under section 714(b) of the
				Employee Retirement Income Security Act of
				1974 with respect to the requirements of this section as if such
				section applied to such
				plan.
								.
					(B)Clerical
			 amendmentThe table of sections for such subchapter is amended by
			 adding at the end the following new item:

								Sec. 9813. Provisions relating to
				prescription
				drugs.

							.
					(b)Individual
			 health insurance
				(1)In
			 generalPart B of title XXVII of the
			 Public Health Service Act is amended
			 by inserting after section 2752 the following new section:

						2754.Provisions
				relating to prescription drugsThe provisions of section 2708 shall apply
				to health insurance coverage offered by a health insurance issuer in the
				individual market in the same manner as they apply to health insurance coverage
				offered by a health insurance issuer in connection with a group health plan in
				the small or large group
				market.
						.
				(2)Conforming
			 amendmentSection 2762(b)(2) of such Act (42 U.S.C.
			 300gg–62(b)(2)) is amended by striking section 2751 and
			 inserting sections 2751 and 2754.
				(c)Application to
			 FEHBPThe amendments made by this section
			 shall apply to the administration of chapter 89
			 of title 5, United States Code.


		II
		112th CONGRESS
		2d Session
		S. 2722
		IN THE SENATE OF THE UNITED STATES

			May 7, 2012
			Mr. Casey introduced the
			 following bill; which was read twice and referred to the
			 Committee on
			 Finance

		A BILL
		To suspend temporarily the duty on
		  spirotetramat.

		1.Spirotetramat
			(a)In
			 generalSubchapter II of chapter 99 of the Harmonized Tariff
			 Schedule of the United States is amended by inserting in numerical sequence the
			 following new heading:

								9902.01.00cis-4-(Ethoxycarbonyloxy)-8-methoxy-3-(2,5-xylyl)-1-azaspiro[4.5]dec-3-en-2-one
						(spirotetramat) (CAS No. 203313–25–1) (provided for in subheading
						2933.79.08)FreeNo changeNo changeOn or before 12/31/2015

					.
			(b)Effective
			 dateThe amendment made by subsection (a) applies with respect to
			 goods entered, or withdrawn from warehouse for consumption, on or after the
			 15th day after the date of the enactment of this Act.


115 S3517 IS: Prevention of Unconstitutional War with Iran Act of 2018
U.S. Senate
2018-09-26
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

		II
		115th CONGRESS2d Session
		S. 3517
		IN THE SENATE OF THE UNITED STATES

			September 26, 2018
			Mr. Udall (for himself, Mr. Leahy, Mrs. Feinstein, Mr. Durbin, Mr. Sanders, Mr. Merkley, Mr. Heinrich, and Mr. Murphy) introduced the following bill; which was read twice and referred to the Committee on Foreign Relations

		A BILL
		To limit the use of funds for kinetic military operations in or against Iran.

		1.Short title
 This Act may be cited as the Prevention of Unconstitutional War with Iran Act of 2018.
 2.FindingsCongress makes the following findings: (1)Article I, Section 8, of the Constitution of the United States grants Congress the sole power to declare war.
 (2)President George Washington, in a letter to William Moultrie dated August 28, 1793, wrote that [t]he constitution vests the power of declaring war in Congress; therefore no offensive expedition of importance can be undertaken until after they shall have deliberated upon the subject and authorized such a measure.
 (3)Alexander Hamilton wrote in Examination Number 1 of the Hamilton Papers, dated December 17, 1801, that [t]he Congress shall have the power to declare war; the plain meaning of which is, that it is the peculiar and exclusive duty of Congress, when the nation is at peace, to change that state into a state of war.
 (4)Iran's support for terrorism presents a serious threat to the United States and our allies in the Middle East, Europe, and Asia.
 (5)Missile tests by Iran have led to escalating tensions with Israel, Saudi Arabia, the United States, and the United Nations.
 (6)Iran has threatened to shutdown crucial maritime lines of communication, putting United States and international naval assets, as well as global energy assets, at risk.
 (7)According to the intelligence assessments of the United States, the Joint Comprehensive Plan of Action curtailed enrichment and prevented processing of fissile materials by Iran to levels which would preclude Iran from developing a nuclear weapon.
 (8)The International Atomic Energy Agency has repeatedly verified that Iran has continued to comply with its nuclear-related obligations as required by the Joint Comprehensive Plan of Action.
 (9)Noncompliance by the United States with the Joint Comprehensive Plan of Action risks an unnecessary conflagration with Iran through the use of sanctions against both allies and adversaries in the region and throughout the world, absent a clear diplomatic path for resolving the crisis.
 (10)A war with Iran would also endanger United States assets, personnel, and foreign policy objectives throughout the region, including in Iraq, Afghanistan, and Israel.
 (11)President Trump tweeted that Iran [w]ill suffer consequences the likes of which few throughout history have ever suffered before. (12)Loose talk of war and belligerent rhetoric increases the risk of miscalculation by either side and unsettles United States allies.
 (13)Section 2(c) of the War Powers Resolution (50 U.S.C. 1541(c)) states that [t]he constitutional powers of the President as Commander-in-Chief to introduce United States Armed Forces into hostilities, or into situations where imminent involvement in hostilities is clearly indicated by the circumstances, are exercised only pursuant to (1) a declaration of war, (2) specific statutory authorization, or (3) a national emergency created by attack upon the United States, its territories or possessions, or its armed forces.
			3.Limitation on use of funds for kinetic military operations in or against Iran
 (a)In generalNo funds may be used for kinetic military operations in or against Iran except pursuant to an Act or joint resolution of Congress specifically authorizing such use that is enacted after the date of the enactment of this Act.
 (b)ExceptionsThe limitation in subsection (a) shall not apply to the following: (1)Kinetic military operations in response to an imminent threat to the United States, as otherwise authorized by applicable statutes and joint resolutions.
 (2)The introduction of the United States Armed Forces into hostilities in order to repel a sudden attack on the United States, its territories or possessions, or its Armed Forces.
 (3)The deployment of United States Armed Forces to rescue or remove United States citizens or personnel.
 (c)Rule of constructionNothing in this section may be construed to relieve the Executive Branch of restrictions on the use of force or reporting requirements set forth in the War Powers Resolution (50 U.S.C. 1541 et seq.).


116 HR 2102 IH: Veterans Exposed to Toxic PFAS Act
U.S. House of Representatives
2019-04-04
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I116th CONGRESS1st SessionH. R. 2102IN THE HOUSE OF REPRESENTATIVESApril 4, 2019Mr. Kildee (for himself, Mrs. Dingell, Ms. Slotkin, Mr. Levin of Michigan, Ms. Tlaib, Mr. Khanna, Mr. Delgado, Ms. Torres Small of New Mexico, Mr. Pappas, Mr. Brendan F. Boyle of Pennsylvania, Mr. Sean Patrick Maloney of New York, Ms. Dean, Mr. Cohen, Ms. Kuster of New Hampshire, Mrs. Lawrence, Ms. Stevens, Mrs. Trahan, and Mr. Kim) introduced the following bill; which was referred to the Committee on Veterans' AffairsA BILLTo amend title 38, United States Code, to furnish hospital care and medical services to veterans
			 and dependents who were stationed at military installations at which the
			 veterans and dependents were exposed to perfluorooctanoic acid or other
			 per- and polyfluoroalkyl substances, to provide for a presumption of
			 service connection for certain veterans who were stationed at military
			 installations at which the veterans were exposed to such substances, and
			 for other purposes.

 1.Short titleThis Act may be cited as the Veterans Exposed to Toxic PFAS Act or the VET PFAS Act. 2.Hospital care and medical services for veterans and dependents exposed to perfluorooctanoic acid and other per- and polyfluoroalkyl substances (a)Hospital care and medical services for veterans (1)In generalParagraph (1) of section 1710(e) of title 38, United States Code, is amended by adding at the end the following new subparagraph:

						(G)
 (i)Beginning on the date that is 90 days after the date of the enactment of this subparagraph, subject to paragraph (2), a veteran who served on active duty in the Armed Forces at a covered military installation at which individuals were exposed to substances specified in clause (ii) is eligible for hospital care and medical services under subsection (a)(2)(F) for the diseases, illnesses, or conditions as specified in such clause, notwithstanding that there is insufficient medical evidence to conclude that such illness or condition is attributable to such service.
 (ii)The substances and diseases, illnesses, or conditions specified in this clause are the following: (I)With respect to exposure to perfluorooctanoic acid—
 (aa)diagnosed high cholesterol; (bb)ulcerative colitis;
 (cc)thyroid disease; (dd)testicular cancer;
 (ee)kidney cancer; and (ff)pregnancy-induced hypertension.
 (II)With respect to exposure to other per- and polyfluoroalkyl substances, any disease, illness, or condition that the Secretary of Veterans Affairs, in consultation with the Administrator of the Agency for Toxic Substances and Disease Registry of the Department of Health and Human Services, determines pursuant to the study conducted under section 316 of the National Defense Authorization Act for Fiscal Year 2018 (Public Law 115–91) that a positive association exists between exposure to per- and polyfluoroalkyl substances and such disease, illness, or condition.
 (iii)For purposes of this subparagraph, any service by a member of the reserve components for a period specified by the Secretary at a covered military installation at which individuals were exposed to substances specified in clause (ii) shall be treated as active duty service, notwithstanding section 101(21) of this title.
 (iv)In this subparagraph, the term covered military installation means a military installation at which individuals were exposed to perfluorooctanoic acid or other per- and polyfluoroalkyl substances, including exposure through a well that provides water for human consumption that is contaminated with such substances..
 (2)LimitationParagraph (2)(B) of such section is amended by striking or (F) and inserting (F), or (G). (b)Family members (1)In generalSubchapter VIII of chapter 17 is amended by adding at the end the following new section:

						1787A.Health care of family members of veterans stationed at certain military installations
 (a)In generalBeginning on the date that is 90 days after the date of the enactment of this section, subject to subsection (b), a family member of a veteran described in clause (i) of section 1710(e)(1)(G) of this title (or who would be so described but for the condition by which the individual was discharged or released from the Armed Forces) who resided at a military installation covered by such clause or who was in utero while the mother of such family member resided at such location shall be eligible for hospital care and medical services furnished by the Secretary for any disease, illness, or condition for which a veteran may receive hospital care and medical services under clause (ii) of such section, notwithstanding that there is insufficient medical evidence to conclude that such disease, illness, or condition is attributable to such residence.
							(b)Limitations
 (1)The Secretary may only furnish hospital care and medical services under subsection (a) to the extent and in the amount provided in advance in appropriations Acts for such purpose.
 (2)Hospital care and medical services may not be furnished under subsection (a) for a disease, illness, or condition of a family member that is found, in accordance with guidelines issued by the Under Secretary for Health, to have resulted from a cause other than the residence of the family member described in that subsection.
 (3)The Secretary may provide reimbursement for hospital care or medical services provided to a family member under this section only after the family member or the provider of such care or services has exhausted without success all claims and remedies reasonably available to the family member or provider against a third party (as defined in section 1725(f) of this title) for payment of such care or services, including with respect to health-plan contracts (as defined in such section)..
 (2)Clerical amendmentThe table of sections at the beginning of such chapter is amended by inserting after the item relating to section 1787 the following new item:

							1787A. Health care of family members of veterans stationed at certain military installations..
				(c)Annual reports
 (1)In generalDuring the three-year period beginning in the year in which the study conducted under section 316 of the National Defense Authorization Act for Fiscal Year 2018 (Public Law 115–91) is submitted to Congress, the Secretary of Veterans Affairs shall submit to the Committee on Veterans’ Affairs of the Senate and the Committee on Veterans’ Affairs of the House of Representatives an annual report on the care and services provided under sections 1710(e)(1)(G) and 1787A of title 38, United States Code (as added by subsections (a) and (b)(1), respectively).
 (2)ElementsEach report under paragraph (1) shall set forth the following: (A)The number of veterans and family members provided hospital care and medical services under the provisions of law specified in paragraph (1) during the period covered by the report.
 (B)The illnesses, conditions, and disabilities for which care and services have been provided such veterans and family members under such provisions of law during that period.
 (C)The number of veterans and family members who applied for care and services under such provisions of law during that period but were denied, including information on the reasons for such denials.
 (D)The number of veterans and family members who applied for care and services under such provisions of law and are awaiting a decision from the Secretary on eligibility for such care and services as of the date of such report.
 (3)Veteran definedIn this subsection, the term veteran includes a former member of the reserve components of the Armed Forces covered by such section 1710(e)(1)(G).
				3.Presumption of service connection for certain veterans exposed to perfluorooctanoic acid or other
			 per- and polyfluoroalkyl substances
 (a)In generalChapter 11 of title 38, United States Code, is amended by inserting after section 1116 the following new section:

					1116A.Presumption of service connection for certain veterans exposed to perfluorooctanoic acid or other
			 per- and polyfluoroalkyl substances
						(a)Presumption of service connection
 (1)For the purposes of section 1110 of this title, and subject to section 1113 of this title, each disease or illness specified in subsection (b) that becomes manifest in a veteran described in paragraph (2) shall be considered to have been incurred or aggravated in the line of duty in the active military, naval, or air service, notwithstanding that there is no record of evidence of such disease or illness during the period of such service.
 (2)A veteran described in this paragraph is a veteran who, during active military, naval, or air service, served at a military installation at which individuals were exposed to perfluorooctanoic acid or other per- and polyfluoroalkyl substances, including exposure through a well that provides water for human consumption that is contaminated with such substances.
 (b)Diseases or illnessesA disease or illness specified in this subsection is any of the following: (1)With respect to exposure to perfluorooctanoic acid—
 (A)diagnosed high cholesterol; (B)ulcerative colitis;
 (C)thyroid disease; (D)testicular cancer;
 (E)kidney cancer; and (F)pregnancy-induced hypertension.
 (2)With respect to exposure to other per- and polyfluoroalkyl substances, any other disease, illness, or condition that the Secretary of Veterans Affairs, in consultation with the Administrator of the Agency for Toxic Substances and Disease Registry of the Department of Health and Human Services, determines pursuant to the study conducted under section 316 of the National Defense Authorization Act for Fiscal Year 2018 (Public Law 115–91) that a positive association exists between exposure to per- and polyfluoroalkyl substances and such disease or illness.
 (c)Active military, naval, or air serviceFor purposes of this section, any service by a member of the reserve components for a period specified by the Secretary at a military installation described in subsection (a)(2) shall be treated as active military, naval, or air service, notwithstanding section 101(24) of this title..
 (b)Clerical amendmentThe table of sections at the beginning of such chapter is amended by inserting after the item relating to section 1116 the following new item:

						1116A. Presumption of service connection for certain veterans exposed to perfluorooctanoic acid or
			 other per- and polyfluoroalkyl substances..


115 S1687 IS: Job Creation through Energy Efficient Manufacturing Act
U.S. Senate
2017-08-01
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

		II
		115th CONGRESS1st Session
		S. 1687
		IN THE SENATE OF THE UNITED STATES

			August 1, 2017
			Mr. Merkley introduced the following bill; which was read twice and referred to the Committee on Energy and Natural Resources

		A BILL
		To establish the Financing Energy Efficient Manufacturing Program at the Department of Energy to
			 provide financial assistance to promote energy efficiency and onsite
			 renewable technologies in manufacturing facilities, and for other
			 purposes.

		1.Short title
 This Act may be cited as the Job Creation through Energy Efficient Manufacturing Act.
 2.DefinitionsIn this Act: (1)Energy management planThe term energy management plan means a plan established under section 3(c)(4).
 (2)ProgramThe term program means the Financing Energy Efficient Manufacturing Program established under section 3(a). (3)Program managerThe term program manager means a qualified entity that receives a grant under section 3(a).
 (4)ProjectThe term project means an energy efficiency improvement project carried out by a small- or medium-sized manufacturer using grant funds distributed by a project manager.
 (5)Qualified entityThe term qualified entity means— (A)a State energy office;
 (B)a nonprofit organization that— (i)is focused on providing energy efficiency or renewable energy services; and
 (ii)receives funding from a State, Tribe, or utility; (C)an electric cooperative group; and
 (D)an entity with a public-private partnership under the Hollings Manufacturing Extension Partnership established under section 25(b) of the National Institute of Standards and Technology Act (15 U.S.C. 278k(b)).
 (6)SecretaryThe term Secretary means the Secretary of Energy. (7)Small- or medium-sized manufacturerThe term small- or medium-sized manufacturer means a manufacturing establishment—
 (A)classified in Sector 31, 32, or 33 in the North American Industry Classification System; and (B)that employs not more than 750 employees.
				3.Financing Energy Efficient Manufacturing Program
 (a)EstablishmentThe Secretary shall establish a program, to be known as the Financing Energy Efficient Manufacturing Program to provide grants to qualified entities to fund energy efficiency improvement projects in the manufacturing sector.
			(b)Grant applications; selection of grant recipients
				(1)Grant applications
 (A)In generalNot later than 180 days after the date of enactment of this Act, qualified entities desiring a grant under subsection (a) shall submit to the Secretary an application in such manner and containing such information as the Secretary may require, including a description of—
 (i)how the qualified entity will work with small- and medium-sized manufacturers to assess the most promising opportunities for energy efficiency improvements;
 (ii)how the qualified entity will work with small- and medium-sized manufacturers and, if appropriate, licensed engineers to establish an energy management plan for the small- or medium-sized manufacturer to carry out a project;
 (iii)the methods and cost-sharing plans the qualified entity will use to distribute funds to small- and medium-sized manufacturers to subsidize the costs of carrying out a project;
 (iv)the standards by which the qualified entity will set energy efficiency goals for a project that will result in meaningful reductions in electricity or natural gas use by the small- or medium-sized manufacturer carrying out the project;
 (v)how the qualified entity will provide support to the small- or medium-sized manufacturer carrying out a project during the implementation of the energy management plan;
 (vi)(I)any history of the qualified entity of working collaboratively with the regional technical assistance programs of the Department of Energy; and
 (II)how the qualified entity plans to involve the regional technical assistance programs in the activities to be funded by a grant; and
 (vii)how the qualified entity will collect measurements throughout the implementation of the energy management plan—
 (I)to demonstrate how energy efficiency improvements are being achieved; and (II)to maximize opportunities for project success.
 (B)PartnershipsTwo or more qualified entities may form a partnership to apply, and act as program manager, for a grant under this subsection.
					(2)Selection of grant recipients
 (A)In generalNot later than 90 days after the date on which the Secretary receives an application under paragraph (1), the Secretary shall—
 (i)review the application; (ii)provide the applicant with an opportunity to respond to any questions of the Secretary regarding the application; and
 (iii)select or deny the applicant based on the criteria described in subparagraph (B). (B)Selection criteria (i)In generalThe Secretary shall select for grants under this subsection qualified entities that demonstrate a history of successfully implementing energy efficiency improvement programs for small- and medium-sized manufacturers.
 (ii)PriorityIn making selections under clause (i), the Secretary shall give priority to qualified entities that demonstrate—
 (I)effective methods for reducing barriers to entry that might otherwise prevent small- and medium-sized manufacturers from participating in the subgrant program under subsection (c);
 (II)flexibility in addressing the needs of different small- and medium-sized manufacturers; and (III)a commitment to hiring for projects contractors that comply with the labor requirements described in subsection (d)(2).
							(c)Subgrants for energy efficiency improvements
 (1)In generalA qualified entity (including a partnership of one or more qualified entities under subsection (b)(1)(B)) that receives a grant under subsection (a) shall act as a program manager to distribute subgrants to small- and medium-sized manufacturers located in the State in which the program manager is located to carry out projects—
 (A)to improve the energy efficiency of the small- or medium-sized manufacturer; and (B)to develop technologies to reduce electricity or natural gas use by the small- or medium-sized manufacturer.
 (2)ApplicationsA small- or medium-sized manufacturer desiring a subgrant under paragraph (1) shall submit to the program manager an application at such time, in such manner, and containing such information as the program manager may require, including a proposal describing the project to be carried out using the subgrant funds.
 (3)PriorityIn selecting small- or medium-sized manufacturers for subgrants under this subsection, the program manager shall give priority to small- or medium-sized manufacturers that commit to hiring for projects contractors that comply with the labor requirements described in subsection (d)(2).
 (4)Eligibility requirementsTo be eligible to receive a subgrant under paragraph (1), a small- or medium-sized manufacturer shall be a private, nongovernmental entity.
 (5)Energy management plansEach small- or medium-sized manufacturer receiving a subgrant under paragraph (1), in consultation with the program manager and, if appropriate, one or more licensed engineers, shall establish an energy management plan for the small- or medium-sized manufacturer to carry out the project.
 (6)Effect on title to propertyThe receipt of Federal funds under this subsection shall not prohibit an entity that purchased equipment or other property using those funds from owning sole, permanent title to the equipment or other property.
				(d)Contractors
 (1)In generalProgram managers and small- or medium-sized manufacturers may hire, if necessary, contractors to perform work relating to the installation, repair, or maintenance of equipment used under a project.
 (2)Labor requirementsIn an application for a grant or subgrant under this section, a program manager or a small- or medium-sized manufacturer, respectively, may commit to hiring contractors that represent to the best of the knowledge and belief of the contractor, whether, during the 3-year period preceding the date of application, any administrative merits determination, arbitral award or decision, or civil judgment (as defined in guidance issued by the Secretary of Labor) was rendered against the contractor for violations of—
 (A)the National Labor Relations Act (29 U.S.C. 151 et seq.); (B)the Fair Labor Standards Act of 1938 (29 U.S.C. 201 et seq.);
 (C)the Age Discrimination in Employment Act of 1967 (29 U.S.C. 621 et seq.); (D)the Occupational Safety and Health Act of 1970 (29 U.S.C. 651 et seq.);
 (E)the Migrant and Seasonal Agricultural Worker Protection Act (29 U.S.C. 1801 et seq.); (F)the Family and Medical Leave Act of 1993 (29 U.S.C. 2611 et seq.);
 (G)subchapter IV of chapter 31 of part A of subtitle II of title 40, United States Code (commonly referred to as the Davis-Bacon Act);
 (H)chapter 67 of title 41, United States Code; (I)title VII of the Civil Rights Act of 1964 (42 U.S.C. 2000e et seq.);
 (J)the Americans with Disabilities Act of 1990 (42 U.S.C. 12101 et seq.); (K)Executive Order 11246 (42 U.S.C. 2000e note) (relating to equal employment opportunity);
 (L)Executive Order 13658 (79 Fed. Reg. 9851 (February 20, 2014)) (relating to establishing a minimum wage for contractors); or
 (M)equivalent State laws. (3)Additional labor requirementsA program manager or small- or medium-sized manufacturer receiving a grant or subgrant, respectively, under this section that has committed to complying with the labor requirements described in paragraph (2)—
 (A)shall provide each contractor an opportunity to disclose any steps taken to correct a violation of, or improve compliance with, a law or Executive order described in any of subparagraphs (A) through (M) of paragraph (2), including any agreements entered into with an enforcement agency;
 (B)shall give preference to contractors that have the fewest number of violations (particularly serious, repeated, willful, or pervasive violations) of the laws and Executive orders described in subparagraphs (A) through (M) of paragraph (2); and
 (C)shall not hire contractors that fail to take steps to correct violations of, or improve compliance with, a law or Executive order described in any of subparagraphs (A) through (M) of paragraph (2).
					(e)American iron, steel, and manufactured products
 (1)DefinitionsIn this subsection: (A)Iron or steel manufactured productThe term iron or steel manufactured product includes any construction material or end product (as those terms are defined in subpart 25.003 of the Federal Acquisition Regulation) that does not otherwise qualify as an iron or steel product, including—
 (i)an electrical component; (ii)a non-ferrous building material, including—
 (I)aluminum and polyvinylchloride; (II)glass;
 (III)fiber optics; (IV)plastic;
 (V)wood; (VI)masonry;
 (VII)rubber; (VIII)manufactured stone; and
 (IX)any other non-ferrous building materials; and (iii)any unmanufactured construction material.
						(B)Produced in the United States
 (i)In generalThe term produced in the United States— (I)with respect to an iron or steel product or an iron or steel manufactured product, means that all manufacturing processes for, and materials and components of, the iron or steel product or iron or steel manufactured product, from the initial melting stage through the application of coatings, occurred in the United States; and
 (II)with respect to an iron or steel manufactured product, means that— (aa)the iron or steel manufactured product was manufactured in the United States; and
 (bb)the cost of the components of the iron or steel manufactured product that were mined, produced, or manufactured in the United States is greater than 60 percent of the total cost of the components of the iron or steel manufactured product.
 (ii)ExclusionsThe term produced in the United States, with respect to an iron or steel product or an iron or steel manufactured product, does not include an iron or steel product or an iron or steel manufactured product that was manufactured—
 (I)abroad from semi-finished steel or iron from the United States; or (II)in the United States from semi-finished steel or iron of foreign origin.
 (2)RequirementFunds made available under the program may not be used for a project unless all of the iron and steel products and iron and steel manufactured products used in the project are produced in the United States.
				(3)Waiver
 (A)In generalOn request of the recipient of a grant under the program, the Secretary may grant for the project of the recipient of the grant a waiver of the requirement described in paragraph (2) if the Secretary finds that—
 (i)the application of paragraph (2) would be inconsistent with the public interest; (ii)iron or steel products or iron or steel manufactured products are not produced in the United States—
 (I)in sufficient and reasonably available quantities; or (II)of a satisfactory quality; or
 (iii)the inclusion of iron or steel products or iron or steel manufactured products produced in the United States would increase the cost of the overall project by greater than 25 percent.
 (B)Public noticeOn receipt of a request for a waiver under subparagraph (A), the Secretary shall— (i)make available to the public, including by electronic means, including on the official public website of the Department of Energy, on an informal basis, a copy of the request and all information available to the Secretary relating to the request; and
 (ii)provide for informal public input on the request for a period of not fewer than 15 days before making with respect to the request the finding described in subparagraph (A).
						(f)Reporting requirements
 (1)In generalEach program manager shall— (A)determine what data shall be required—
 (i)to be collected by or from each small- or medium-sized manufacturer receiving a subgrant under subsection (c); and
 (ii)to be submitted to the program manager to permit analysis of the subgrant program under subsection (c); and
 (B)develop metrics to determine the success of the subgrant program under subsection (c). (2)Provision of dataAs a condition of receiving a subgrant under subsection (c), a small- or medium-sized manufacturer shall provide to the program manager relevant data, as determined by the program manager under paragraph (1)(A).
 (3)Proprietary informationIn carrying out this subsection, each program manager, as appropriate, shall provide for the protection of proprietary information and intellectual property rights.
				(g)Funding
 (1)In generalOut of amounts made available to the Secretary and not otherwise obligated, the Secretary shall use to carry out this section not more than $600,000,000.
 (2)Requirements for program managersA program manager shall use not greater than 7 percent of the grant funds received by the program manager, at the discretion of the program manager—
 (A)to hire and train staff to assist the program manager in administering the subgrant program of the program manager; and
 (B)to market the subgrant program to small- and medium-sized manufacturers. (3)Management and oversightThe Secretary may use not greater than 0.25 percent of the funds made available under paragraph (1) to carry out subsection (e).


		VI
		111th CONGRESS
		1st Session
		S. 550
		IN THE SENATE OF THE UNITED STATES

			March 9, 2009
			Mr. Burris introduced
			 the following bill; which was read twice and referred to the
			 Committee on the
			 Judiciary

		A BILL
		For the relief of Francisca Lino.

		1.Permanent resident status for
			 Francisca Lino
			(a)In
			 GeneralNotwithstanding
			 subsections (a) and (b) of section 201 of the Immigration and Nationality Act (8 U.S.C. 1151),
			 Francisca Lino shall be eligible for issuance of an immigrant visa or for
			 adjustment of status to that of an alien lawfully admitted for permanent
			 residence upon filing an application for issuance of an immigrant visa under
			 section 204 of such Act (8 U.S.C. 1154) or for adjustment of status to lawful
			 permanent resident.
			(b)Adjustment of
			 StatusIf Francisca Lino
			 enters the United States before the filing deadline specified in subsection
			 (c), she shall be considered to have entered and remained lawfully and shall,
			 if otherwise eligible, be eligible for adjustment of status under section 245
			 of the Immigration and Nationality Act
			 (8 U.S.C. 1255) as of the date of the enactment of this Act.
			(c)Deadline for
			 Application and Payment of FeesSubsections (a) and (b) shall
			 apply only if the application for issuance of an immigrant visa or the
			 application for adjustment of status is filed with appropriate fees within 2
			 years after the date of the enactment of this Act.
			(d)Reduction of
			 Immigrant Visa NumberUpon
			 the granting of an immigrant visa or permanent residence to Francisca Lino, the
			 Secretary of State shall instruct the proper officer to reduce by one, during
			 the current or next following fiscal year, the total number of immigrant visas
			 that are made available to natives of the country of the alien’s birth under
			 section 203(a) of the Immigration and Nationality
			 Act (8 U.S.C. 1153(a)) or, if applicable, the total number of
			 immigrant visas that are made available to natives of the country of the
			 alien’s birth under section 202(e) of such Act (8 U.S.C. 1152(e)).
			(e)Denial of
			 Preferential Immigration Treatment for Certain RelativesThe natural parents, brothers, and sisters
			 of Francisca Lino shall not, by virtue of such relationship, be accorded any
			 right, privilege, or status under the Immigration
			 and Nationality Act.


116 HR 939 IH: Safety Enhancements for Communities Using Reasonable and Effective Firearm Storage Act
U.S. House of Representatives
2019-01-31
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I116th CONGRESS1st SessionH. R. 939IN THE HOUSE OF REPRESENTATIVESJanuary 31, 2019Mr. Schneider (for himself, Ms. Pingree, Mr. Quigley, Ms. Kelly of Illinois, Mr. Cohen, Ms. Norton, Mr. Hastings, Ms. Schakowsky, Mr. Swalwell of California, Mr. Carbajal, Mr. McGovern, and Mr. Langevin) introduced the following bill; which was referred to the Committee on the JudiciaryA BILLTo amend title 18, United States Code, to require federally licensed firearms importers,
			 manufacturers, and dealers to meet certain requirements with respect to
			 securing their firearms inventory, business records, and business
			 premises.

 1.Short titleThis Act may be cited as the Safety Enhancements for Communities Using Reasonable and Effective Firearm Storage Act or the SECURE Firearm Storage Act. 2.Security requirements for federally licensed firearms importers, manufacturers, and dealers (a)In generalSection 923 of title 18, United States Code, is amended by adding at the end the following:

					(m)Security requirements
 (1)Relation to provision governing gun showsThis subsection shall apply to a licensed importer, licensed manufacturer, or licensed dealer except as provided in subsection (j).
						(2)Firearm storage
 (A)In generalA person who is a licensed importer, licensed manufacturer, or licensed dealer shall keep and store each firearm in the business inventory of the licensee at the premises covered by the license.
 (B)Means of storageWhen the premises covered by the license are not open for business, the licensee shall, with respect to each firearm in the business inventory of the licensee—
 (i)secure the firearm with a hardened steel rod 1/4 inch thick through the space between the trigger guard, and the frame or receiver, of the firearm, with—
 (I)the steel rod secured by a hardened steel lock that has a shackle; (II)the lock and shackle protected or shielded from the use of a bolt cutter; and
 (III)the rod anchored to prevent the removal of the firearm from the premises; or (ii)store the firearm in—
 (I)a locked fireproof safe; (II)a locked gun cabinet (and if the locked gun cabinet is not steel, each firearm within the cabinet shall be secured with a hardened steel rod 1/4 inch thick, protected or shielded from the use of a bolt cutter and anchored to prevent the removal of the firearm from the premises); or
 (III)a locked vault. (3)Paper record storageWhen the premises covered by the license are not open for business, the licensee shall store each paper record of the business inventory and firearm transactions of, and other dispositions of firearms by, the licensee at the premises in a secure location such as a locked fireproof safe or locked vault.
 (4)Additional security requirementsThe Attorney General may, by regulation, prescribe such additional security requirements as the Attorney General determines appropriate with respect to the firearms business conducted by a licensed importer, licensed manufacturer, or licensed dealer, such as requirements relating to the use of—
 (A)alarm and security camera systems; (B)site hardening;
 (C)measures to secure any electronic record of the business inventory and firearm transactions of, and other dispositions of firearms by, the licensee; and
 (D)other measures necessary to reduce the risk of theft at the business premises of a licensee.. (b)PenaltiesSection 924 of title 18, United States Code, is amended by adding at the end the following:

					(q)Penalties for noncompliance with firearms licensee security requirements
						(1)In general
 (A)PenaltyWith respect to a violation by a licensee of section 923(m) or a regulation issued under that section, the Attorney General, after notice and opportunity for hearing—
 (i)in the case of the first violation or related series of violations on the same date, shall subject the licensee to a civil penalty in an amount equal to not less than $1,000 and not more than $10,000;
 (ii)in the case of the second violation or related series of violations on the same date— (I)shall suspend the license issued to the licensee under this chapter until the licensee cures the violation; and
 (II)may subject the licensee to a civil penalty in an amount provided in clause (i); or (iii)in the case of the third violation or related series of violations on the same date—
 (I)shall revoke the license issued to the licensee under this chapter; and (II)may subject the licensee to a civil penalty in an amount provided in clause (i).
 (B)ReviewAn action of the Attorney General under this paragraph may be reviewed only as provided under section 923(f).
 (2)Administrative remediesThe imposition of a civil penalty or suspension or revocation of a license under paragraph (1) shall not preclude any administrative remedy that is otherwise available to the Attorney General..
 (c)Application requirementSection 923 of title 18, United States Code, is amended— (1)in subsection (a), in the second sentence, by striking be in such form and contain only that and inserting describe how the applicant plans to comply with subsection (m) and shall be in such form and contain only such other; and
 (2)in subsection (d)(1)— (A)in subparagraph (F), by striking and at the end;
 (B)in subparagraph (G), by striking the period at the end and inserting ; and; and (C)by adding at the end the following:

 (H)the Attorney General determines that the description in the application of how the applicant plans to comply with subsection (m) would, if implemented, so comply..
					(d)Effective dates
 (1)Initial firearm storage requirementsSection 923(m)(2) of title 18, United States Code, as added by subsection (a), shall take effect on the date that is 1 year after the date of enactment of this Act.
 (2)Initial paper records storage requirementsSection 923(m)(3) of title 18, United States Code, as added by subsection (a), shall take effect on the date that is 90 days after the date of enactment of this Act.


114 HR 4117 IH: TRUST Act of 2015
U.S. House of Representatives
2015-11-19
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I
114th CONGRESS
1st Session
H. R. 4117
IN THE HOUSE OF REPRESENTATIVES

November 19, 2015
Mr. Murphy of Florida (for himself, Mr. Rangel, Ms. Norton, and Mr. Honda) introduced the following bill; which was referred to the Committee on the Judiciary

A BILL
To require statistics relating to community trust in law enforcement in the National Crime Victim’s Survey, and for other purposes.

1.Short titleThis Act may be cited as the Tracking Reputations Upgrades Societal Trust Act of 2015 or the TRUST Act of 2015. 2.Required inclusion in the National Crime Victim's Survey of statistics relating to community trust in law enforcementNot later than 270 days after the date of enactment of this Act, as part of each National Crime Victim's Survey, the Attorney General shall include statistics relating to the level of trust by the residents of a State or unit of local government in each law enforcement agency that serves that jurisdiction.
3.Report to CongressNot later than 18 months after the date of enactment of this Act, and annually thereafter, the Attorney General shall submit to Congress a report that includes recommendations of the Attorney General on actions that may be taken to improve the level of trust by residents of a State or unit of local government in law enforcement agencies serving that jurisdiction, if the results of the statistics required to be included in the National Crime Victim's Survey by section 2 of this Act indicate that such level of trust is, in the determination of the Attorney General, problematically low.


110 HR 3362 IH: Tax Fairness for Small Business Act of 2007
U.S. House of Representatives
2007-08-03
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I
110th CONGRESS
1st Session
H. R. 3362
IN THE HOUSE OF REPRESENTATIVES

August 3, 2007
Mr. Pomeroy (for himself and Mr. Cantor) introduced the following bill; which was referred to the Committee on Ways and Means

A BILL
To amend the Internal Revenue Code of 1986 to allow 5-year amortization of goodwill and other section 197 intangibles that are acquired from a small business.

1.Short titleThis Act may be cited as the Tax Fairness for Small Business Act of 2007.
2.5-year amortization of certain intangibles acquired from eligible small businesses
(a)In generalSection 197 of the Internal Revenue Code of 1986 (relating to amortization of goodwill and certain other intangibles) is amended by redesignating subsection (g) as subsection (h) and inserting after subsection (f) the following new subsection:

(g)5-year amortization of intangibles acquired from eligible small businesses
(1)In generalIn the case of any qualified amortizable section 197 intangible, subsection (a) shall be applied by substituting 5-year period for 15-year period.
(2)Qualified amortizable section 197 intangibleFor purposes of this subsection, the term qualified amortizable section 197 intangible means any amortizable section 197 intangible which is acquired in a transaction (or series of transactions) involving the acquisition of assets constituting a trade or business or substantial portion thereof from an eligible small business (as defined in section 474(c)) after December 31, 2006.
(3)Maximum amount per business
(A)In generalThe aggregate adjusted basis of qualified amortizable section 197 intangibles of each eligible small business which the taxpayer may amortize under paragraph (1) shall not exceed $5,000,000.
(B)Allocation of dollar amount
(i)Controlled groupFor purposes of applying the dollar limitations in subparagraph (A)—
(I)all component members of a controlled group shall be treated as one taxpayer, and
(II)such dollar limitations shall be allocated among the component members of such controlled group in such manner as the Secretary prescribes.For purposes of the preceding sentence, the term controlled group has the meaning given to such term by section 1563(a), except that more than 50 percent shall be substituted for at least 80 percent each place it appears in section 1563(a)(1).
(ii)Partnerships and S corporationsIn the case of a partnership, the dollar limitations in subparagraph (A) shall apply with respect to the partnership and with respect to each partner. A similar rule shall apply in the case of an S corporation and its shareholders.
(C)Subsection not to apply to trustsThis subsection shall not apply to trusts.
(D)EstatesThe benefit of the special deduction provided by this subsection shall be allowed to estates in the same manner as in the case of an individual. The allowable deduction shall be apportioned between the income beneficiary and the fiduciary in the manner prescribed by the Secretary. Any amount so apportioned to a beneficiary shall be taken into account for purposes of determining the amount allowable as a deduction under this subsection to such beneficiary..
(b)Effective dateThe amendment made by this section shall apply to acquisitions of qualified amortizable section 197 intangibles (as defined in section 197(g)(2) of the Internal Revenue Code of 1986, as added by this section) after December 31, 2006.


110 HR 4374 IH: To extend the temporary suspension of duty on

U.S. House of Representatives
2007-12-11
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

		I
		110th CONGRESS
		1st Session
		H. R. 4374
		IN THE HOUSE OF REPRESENTATIVES

			December 11, 2007
			Mr. Burton of Indiana
			 introduced the following bill; which was referred to the
			 Committee on Ways and
			 Means

		A BILL
		To extend the temporary suspension of duty on
		  2-Phenylphenol sodium salt.

		1.2–Phenylphenol sodium
			 salt
			(a)In
			 generalHeading 9902.22.10 of
			 the Harmonized Tariff Schedule of the United States (relating to 2–Phenylphenol
			 sodium salt) is amended by striking the date in the effective period column and
			 inserting 12/31/2011.
			(b)Effective
			 dateThe amendment made by
			 subsection (a) applies to goods entered, or withdrawn from warehouse for
			 consumption, on or after the 15th day after the date of the enactment of this
			 Act.


117 HR 5322 IH: Students and Young Consumers Empowerment Act
U.S. House of Representatives
2021-09-22
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I117th CONGRESS1st SessionH. R. 5322IN THE HOUSE OF REPRESENTATIVESSeptember 22, 2021Ms. Bonamici (for herself, Ms. Porter, Ms. Dean, Ms. Tlaib, Ms. Norton, and Mr. Case) introduced the following bill; which was referred to the Committee on Education and Labor, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concernedA BILLTo amend the Consumer Financial Protection Act of 2010 to establish the position of the Assistant Director and Student Loan Borrower Advocate of the Bureau of Consumer Financial Protection, to establish the Office for Students and Young Consumers of the Bureau, and for other purposes.1.Short titleThis Act may be cited as the Students and Young Consumers Empowerment Act.2.Assistant Director and Student Loan Borrower Advocate(a)In generalSection 1035 of the Consumer Financial Protection Act of 2010 (12 U.S.C. 5535) is amended to read as follows:1035.Assistant Director and Student Loan Borrower Advocate(a)EstablishmentThere is established the position of Assistant Director and Student Loan Borrower Advocate, who shall be appointed by the Director.(b)DutiesThe Assistant Director and Student Loan Borrower Advocate shall—(1)serve as the head of the Office for Students and Young Consumers established under subsection (e);(2)not later than the end of the 60-day period beginning on the date of enactment of this section, enter into a memorandum of understanding with the Secretary of Education, the Chief Operating Officer appointed under section 141(d) of the Higher Education Act of 1965 (20 U.S.C. 1018(d)), and the Student Loan Ombudsman appointed under section 141(f) of the Higher Education Act of 1965 (20 U.S.C. 1018(f)) that—(A)ensures coordination in providing assistance to and serving borrowers seeking to resolve complaints related to their private education or Federal student loans; and(B)authorizes the Bureau to access all relevant Department of Education information systems, records, and data, including any relevant information systems, records, or data maintained by contractors of the Department of Education;(3)accept and attempt to resolve complaints from borrowers with both private education loans and Federal student loans, including complaints against lenders, servicers, and debt collectors; and(4)carry out such other duties as the Director may determine appropriate.(c)Notification to CongressThe Director shall provide written notice and an explanation to the appropriate congressional committees, if—(1)the position of the Assistant Director and Student Loan Borrower Advocate has been vacant for a period of 60 days or more; or(2)the memorandum of understanding required under subsection (b)(2) has lapsed for a period of 60 days or more.(d)Reports(1)Annual report on the student loan marketplaceThe Assistant Director and Student Loan Borrower Advocate shall—(A)compile and analyze complaints from borrowers with Federal student loans or private education loans;(B)not less than once per year, submit a report to Congress summarizing the activities of the Assistant Director and Student Loan Borrower Advocate in the previous year and including an independent evaluation of risks to consumers posed by policies and practices in the student loan marketplace; and(C)as part of each report submitted in accordance with subparagraph (B), and any other time deemed prudent by the Student Loan Borrower Advocate, make recommendations to the Director, the Secretary of the Treasury, the Secretary of Education, and the appropriate congressional committees to address risk to student loan borrowers and strengthen the student loan marketplace.(2)Annual report on campus bankingNot less than once per year, the Assistant Director and Student Loan Borrower Advocate shall issue a report to the appropriate congressional committees analyzing the use of consumer financial products and services by students enrolled at institutions of higher education, including an evaluation of contracts and other financial arrangements between institutions of higher education and providers of consumer financial products and services, including an evaluation of revenue sharing provisions, marketing provisions, and fees assessed to students who use such products and services.(3)Report on risks to young consumersNot less than once per year, the Assistant Director and Student Loan Borrower Advocate shall issue a report to the appropriate congressional committees containing an analysis of complaints submitted to the Bureau by young consumers during the previous year and offering an independent evaluation of risks to consumers posed by policies and practices in the marketplace for consumer financial products and services.(e)Office for Students and Young ConsumersThere is established an Office for Students and Young Consumers, which shall be responsible for developing and implementing initiatives for students, young consumers, and their families intended to—(1)educate and empower students, young consumers, and their families to make better informed decisions regarding consumer financial products and services; and(2)coordinate efforts among Federal and State agencies, as appropriate, regarding consumer protection measures relating to consumer financial products and services offered to, or used by, students, young consumers, and their families.(f)Collection of information; market monitoring(1)In generalIn carrying out this section, the Assistant Director and Student Loan Borrower Advocate shall have the authority to gather information from time to time regarding the organization, business conduct, markets, and activities of covered persons and service providers.(2)Sources of informationIn gathering information described under paragraph (1), the Assistant Director and Student Loan Borrower Advocate may gather and compile information from a variety of sources, including examination reports concerning covered persons or service providers, consumer complaints, voluntary surveys and voluntary interviews of consumers, surveys and interviews with covered persons and service providers, and review of available databases.(3)Authority to require reports and other informationThe Director shall, upon the recommendation of the Assistant Director and Student Loan Borrower Advocate, require covered persons and service providers participating in consumer financial services markets to file with the Bureau, under oath or otherwise, in such form and within such reasonable period of time as the Bureau may prescribe by rule or order, annual or special reports, answers in writing to specific questions, or other information described under section 1022(c)(4).(4)LimitationThe Bureau may not use its authorities under this subsection to obtain records from covered persons and service providers participating in consumer financial services markets for purposes of gathering or analyzing the personally identifiable financial information of consumers.(g)DefinitionsFor purposes of this section:(1)Appropriate congressional committeesThe term appropriate congressional committees means the Committees on Education and Labor and Financial Services of the House of Representatives and the Committees on Banking, Housing, and Urban Affairs and Health, Education, Labor, and Pensions of the Senate.(2)Truth in Lending Act termsThe terms private education loan and institution of higher education have the meanings given those terms, respectively, under section 140 of the Truth in Lending Act (15 U.S.C. 1650)..(b)Clerical amendmentThe table of contents under section 1(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act is amended, in the item relating to section 1035, by striking Private Education Loan Ombudsman and inserting Assistant Director and Student Loan Borrower Advocate.3.Duties of the Department of EducationPart D of title I of the Higher Education Act of 1965 (20 U.S.C. 1018 et seq.) is amended by adding at the end the following:144.Memorandum of understanding with the Assistant Director and Student Loan Borrower AdvocateNot later than the end of the 60-day period beginning on the date of enactment of this section, the Secretary of Education, the Chief Operating Officer appointed under section 141(d), and the Student Loan Ombudsman appointed under section 141(f) shall enter into a memorandum of understanding with the Assistant Director and Student Loan Borrower Advocate of the Bureau of Consumer Financial Protection that—(1)ensures coordination in providing assistance to and serving borrowers seeking to resolve complaints related to their private education loans or loans made, insured, or guaranteed under title IV; and(2)authorizes the Bureau to access all relevant Department information systems, records, and data, including any relevant information systems, records, or data maintained by contractors of the Department..


109 HR 254 IH: Baby Abandonment Prevention Act of 2005
U.S. House of Representatives
2005-01-06
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I
109th CONGRESS
1st Session
H. R. 254
IN THE HOUSE OF REPRESENTATIVES

January 6, 2005
Ms. Jackson-Lee of Texas introduced the following bill; which was referred to the Committee on the Judiciary, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL
To provide for the establishment of a task force within the Bureau of Justice Statistics to gather information about, study, and report to the Congress regarding, incidents of abandonment of infant children.

1.Short titleThis Act may be cited as the Baby Abandonment Prevention Act of 2005.
2.Establishment of task force
(a)In generalThe Attorney General, acting through the Director of the Bureau of Justice Statistics, shall establish a task force (to be known as the Task Force on Baby Abandonment) to carry out the following:
(1)Collecting information from State and local law enforcement agencies and child welfare agencies regarding incidents of abandonment of an infant child by a parent of that child.
(2)Maintaining that information in a comprehensive database.
(3)Studying that information and making findings, conclusions, and recommendations regarding that information.
(4)Submitting reports in accordance with this section.
(b)Information includedThe information referred to in subsection (a) shall include information with respect to the following:
(1)The prevalence of such incidents.
(2)The demographics of such children and such parents.
(3)The factors that influence the decision of such parents to abandon such children.
(4)The circumstances surrounding such abandonments, including the time, place, and manner of such abandonments.
(5)The outcomes for such children and such parents after such abandonments.
(6)Trends and variations in the matters set forth in paragraphs (1) through (5).
(c)DefinitionIn this section, the term infant child means a child not more than 12 months of age.
(d)ReportsNot later than one year after the date of the enactment of this Act, and annually thereafter, the task force shall submit a report to the Congress detailing its methodology, findings, conclusions, and recommendations.